The same study postulated that NAFLD and diabetes could be different sides of the same coin, since NAFLD is also involved in the development of diabetes, by increasing glucose production in the liver and exacerbating hepatic insulin resistance through the activation of hepatic protein kinase and some liver-secreted proteins with diabetogenic properties. The gene discussed is WEE1; the disease is metabolic dysfunction-associated steatotic liver disease.